GeneralConnection.com ➔ Dictionary
Dictionary Search

mitomycin

Synonyms

Noun

1. Mutamycin

2. antibiotic, antibiotic drug

Usage
Sandip Prasad, MD, highlights 3-year data on mitomycin for intravesical solution for LG-IR-NMIBC - Urology Times
Mitomycin Exhibits Sustained 36-Month Responses in LG-IR-NMIBC - CancerNetwork
Trabeculectomy with Mitomycin C for Refractory Glaucoma in Chandler’s Variant ICE Syndrome: Clinical Outcomes in a Young Adult - Vera Health
Mitomycin Delivers Lasting Results in Hard-to-Treat Bladder Cancer, Phase 3 Data Show - Pharmacy Times
EAU 2026: BCG + Mitomycin Versus BCG Alone as Adjuvant Intravesical Therapy for High-Risk NMIBC: Effects on Urinary Symptoms and Other Aspects of Health Related Quality of Life in a Randomized Trial (ANZUP 1301) - UroToday
Targeting the DNA damage response prevents regrowth of colorectal peritoneal metastasis-derived organoids following treatment with mitomycin C - Nature
Safe Administration of Mitomycin in Bladder Instillation for Cancer: A Pilot Study - Wiley Online Library
Non-white Ethnicity, Lower Dose of Mitomycin C Associated with Increased Surgical Failure in MIBS - Review of Optometry
UroGen Announces Agreement Resolving Patent Litigation - GlobeNewswire
Mitomycin Administration via Nephrostomy Tube Enhances Nursing Competency - CancerNetwork
Evolving use of mitomycin solution in recurrent NMIBC - Urology Times
ENVISION Trial Analysis: Reverse Thermal Gel with Mitomycin Outcomes by EORTC Risk Group – William Huang - UroToday
Mitomycin Exhibits Sustained 24-Month Survival in NMIBC Population - CancerNetwork
Permanent J code for mitomycin for intravesical solution now in effect - Urology Times
Intravesical Mitomycin Hydrogel: Patient-Reported Outcomes Data from OPTIMA II, ATLAS, and ENVISION - Charles Peyton - UroToday
Discussing Multidisciplinary Coordination for Mitomycin Gel Delivery - CancerNetwork
Review highlights efficacy, safety of mitomycin for intravesical solution in LG-IR-NMIBC - Urology Times
How to bill for mitomycin for intravesical solution in NMIBC - Urology Times
CMS issues permanent J code for mitomycin for intravesical solution for LG-IR-NMIBC - Urology Times
Clinicians explore real-world use of mitomycin for intravesical solution for bladder preservation - Urology Times
Integrating mitomycin for intravesical solution into practice: Insights from urologists - Urology Times
Effective Management of Recurrent Conjunctival Intraepithelial Neoplasia Using Topical Mitomycin C 0.02% - Cureus
OPTIMA II Five-Year Data: Mitomycin Chemoablation Provides Durable Response in LG-IR-NMIBC - Neal Shore - UroToday
One-year outcomes of trabeculectomy with mitomycin C in secondary glaucoma due to posner-schlossman syndrome - Nature
Patient-Reported Outcomes and Qualitative Insights Inform Shared Decision-Making for Mitomycin Intravesical Solution - Ruchika Talwar - UroToday
Intravesical Mitomycin Produces Enduring Efficacy Across NMIBC Trials - CancerNetwork
Mitomycin Intravesical Solution: First Approval - Springer Nature Link
Home-Based Mitomycin Instillation Shows Promise for Low-Grade Bladder Cancer - Targeted Oncology
A Multi-Center Study Examines Maintenance Schedules for Intermediate-Risk NMIBC - Roberto Contieri - UroToday
Home instillation of mitomycin intravesical solution found feasible, safe in NMIBC - Urology Times
Sandip Prasad, MD, on the approval of mitomycin intravesical solution for LG-IR-NMIBC - Urology Times
Updated ENVISION data show sustained efficacy of mitomycin intravesical solution for LG-IR-NMIBC - Urology Times
Durable Efficacy of Intravesical Mitomycin Confirmed in Phase 3 Trial for NMIBC - Targeted Oncology
Comparison of the Effectiveness of Tamoxifen and Mitomycin C in the Prevention of Recurrent Urethral Stricture Following Internal Optical Urethrotomy (IOU): A Randomized Controlled Trial - Cureus
Mitomycin Exhibits Durable Responses in Recurrent, Low-Grade NMIBC - CancerNetwork
Intravesical Mitomycin Demonstrates 24-Month Durability in Recurrent Low-Grade, Intermediate-Risk NMIBC - OncLive
William Huang, MD, outlines OPTIMA II data on mitomycin for intravesical solution - Urology Times
Mitomycin intravesical solution demonstrates long-term durability in LG-IR-NMIBC - Urology Times
Sandip Prasad, MD, on key data from pivotal ENVISION trial of mitomycin intravesical solution - Urology Times
Analyzing Safety and Effectiveness of Topical IFNα2b and Mitomycin C for Localized CIN - Physician's Weekly
Chemoablation broadens treatment options in recurrent NMIBC - Urology Times
Topical versus interlesional mitomycin C in auricular keloids - Elsevier
The Mitomycin C from Nippon Kayaku Co. - a quiet workhorse in cancer care - AD HOC NEWS
Expanding Treatment Options: FDA Approval of Mitomycin Intravesical Solution for Recurrent Low-Grade Intermediate-Risk NMIBC - Sandip Prasad - UroToday
Teva gets Sept. 15, 2030 license for generic JELMYTO drug - Stock Titan
FDA Approves Intravesical Mitomycin in Non–Muscle-Invasive Bladder Cancer - Targeted Oncology
FDA Approves Mitomycin Intravesical Solution (Zusduri) for Non-Muscle Invasive Bladder Cancer - Oncology News Central
FDA Approves Intravesical Mitomycin for Recurrent, Low-Grade, Intermediate-Risk NMIBC - OncLive
Safety and efficacy of a unique scleral flap in mitomycin C-augmented trabeculectomy over one year - Nature
UroGen Reports ZUSDURI™ Revenue More Than Doubled - GlobeNewswire
Mitomycin Intravascular Chemoembolization: A Treatment for Corneal Neovascularization - Rush University Medical Center
Comparison of Intravesical Bacillus Calmette-Guérin (BCG) and Mitomycin C for the Treatment of Non-Muscle-Invasive Bladder Cancer - Cureus
RX Review: How mitomycin for intravesical solution works in treating LG-IR-NMIBC - Urology Times
Mitomycin C-treated dendritic cells inactivate autoreactive T cells: Toward the development of a tolerogenic vaccine in autoimmune diseases - PNAS
Mitomycin/BCG Combo Could Alleviate BCG Shortage Concerns for NMIBC - OncLive
Intravesical Mitomycin in LG-IR-NMIBC Stands Up to Other Options - Targeted Oncology
Can CPT 53899 be used to bill for mitomycin injection? - Urology Times
Mitomycin Intravesical Solution Gains FDA Approval for Recurrent Low-Grade NMIBC - The American Journal of Managed Care® (AJMC®)
Mitomycin C eliminates cyanobacterial transcription without detectable prophage induction in a Microcystis -dominated harmful algal bloom in Lake Erie - American Society for Microbiology
FDA Approves Mitomycin Solution in Low-Grade Intermediate-Risk NMIBC - CancerNetwork
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice - Urology Times
Neoadjuvant Mitomycin C Demonstrates Favorable Safety and Potential RFS Benefit in NMIBC - OncLive
Sequential Mitomycin With BCG Is Shown to Be Safe in High-Risk NMIBC - Targeted Oncology
Mitomycin Intravesical Solution Receives FDA Approval for Non–Muscle-Invasive Bladder Cancer - Pharmacy Times
Professor Dickon Hayne shares data on mitomycin plus BCG in high-risk NMIBC - Urology Times
ZUSDURI™ FDA Approved for Low-Grade Intermediate-Risk Bladder Cancer - Mark Schoenberg - UroToday
Intravesical Mitomycin Demonstrates Significant Duration of Response in NMIBC - Targeted Oncology
Transient Mitomycin C-treatment of human corneal epithelial cells and fibroblasts alters cell migration, cytokine secretion, and matrix accumulation - Nature
Data supports mitomycin plus BCG as alternative to BCG alone in NMIBC - Urology Times
Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer - Frontiers
Mitomycin gel shows promise in patients with UTUC and imperative indications for therapy - Urology Times
FDA Approves Mitomycin Intravesical Solution for Recurrent Low-Grade Intermediate-Risk Non–Muscle-Invasive Bladder Cancer - The ASCO Post
Stability of refractive outcomes after hyperopic LASIK with and without Mitomycin C application: a randomized controlled trial - Nature
U.S. FDA Approves UroGen’s ZUSDURI™ (mitomycin) for Intravesical Solution as the First and Only Medication for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC) - Business Wire
New Intravesical Therapy Approved for Non-muscle Invasive Bladder Cancer - American Association for Cancer Research (AACR)
EP. 3A: Mitomycin Gel for the Treatment of Low-grade Upper Tract Urothelial Carcinoma - Urology Times
A rare case of Fanconi anemia with Mitomycin C sensitivity: A pediatrics case report - Wiley Online Library
Mitomycin Reverse Thermal Gel Shows Complete Response in LG-IR-NMIBC - Targeted Oncology
A set of molecular markers predicts chemosensitivity to Mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis - Nature
Mitomycin induced the senescence of alveolar epithelial cells by targeting peroxiredoxin I - ScienceDirect.com
Antegrade instillation of mitomycin gel is effective in patients with UTUC - Urology Times
Mitomycin C Reduces the Number of Procedures Following NMIBC Recurrence - OncLive
Dr Hayne on Mitomycin/BCG as an Alternative to BCG Alone in Non–Muscle-Invasive Bladder Cancer - OncLive
Long-term outcomes of Mitomycin-C augmented trabeculectomy using subconjunctival injections versus soaked sponges: a randomised controlled trial | Eye - Nature
Neoadjuvant Mitomycin C Shows Favorable Safety in Bladder Cancer - Cure Today
Intravesical hyperthermia with high-dose mitomycin-C shows promise as BCG alternative for NMIBC - Urology Times
Case report: Combination technique of balloon dilation, membrane excision, and topical mitomycin C for the treatment of nasopharyngeal stenosis in a cat - Frontiers
Mitomycin Gel for Low-Grade Upper Tract Urothelial Cancer - The ASCO Post
Increase in corneal haze after corneal crosslinking connected with mitomycin C - Modern Retina
PIPAC-MMC Plus FOLFIRI Shows Feasibility, Safety in Peritoneal Metastases - CancerNetwork
Use of Mitomycin C in the Treatment of Conjuntival Primary Acquired Melanosis With Atypia - ARVO Journals
Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair - Nature
Prevalence of ptosis after topical mitomycin C therapy for conjunctival neoplasia - ARVO Journals
Timing of Adjuvant Mitomycin C Administration May Impact Bladder Cancer Recurrence Following Nephroureterectomy - UF Health
Corneal haze after corneal cross-linking associated with mitomycin C - Ophthalmology Times Europe
Mitomycin-C Improves Amniotic Membrane Graft Outcomes for Socket Reconstruction - Ophthalmology Advisor
FDA Approves Mitomycin Gel for Urothelial Cancer - OncLive
RX Review: A paradigm shift for low-grade, intermediate-risk NMIBC - Urology Times
Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1–Bad–Bak pathway in peritoneal carcinomatosis | Cell Death & Disease - Nature
RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC - Urology Times
Foreign Language Equivalents
Foreign Language Equivalents of 'mitomycin'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
mitomycinn,   miitomycin,   mitomycn,   ,itomycin,   miotmycin,   itomycin,   mitomtcin,   mitomyicn,   miromycin,   mtomycin,   mitmoycin,   mitomycim,   mitomyycin,   mitomycib,   mitomyci,   nitomycin,   mitomyccin,   miyomycin,   mmitomycin,   mito,ycin,   mitonycin,   mitoymcin,   mitoomycin,   mitomucin,   mitmycin,   mutomycin,   mitimycin,   mitomycni,   mitomyxin,   mittomycin,   miomycin,   mitomcyin,   mitommycin,   mitomcin,   mitomyciin,   mitomyin,   motomycin,   imtomycin,   mitomycun,   mitomyvin,   mtiomycin,   mitoycin,   mitomycon,   mitpmycin
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z